Home / Healthcare/ Breathe Free Lanka partners Novartis to provide Ultibro Breezhaler

Breathe Free Lanka partners Novartis to provide Ultibro Breezhaler


Comments / {{hitsCtrl.values.hits}} Views / Thursday, 22 August 2019 00:00


  • Once-daily maintenance solution for COPD patients

 

Breathe Free Lanka Ltd., a subsidiary of Cipla Ltd. has announced a partnership with Novartis for the marketing and distribution of Novartis’ Ultibro Breezhaler.

This partnership will enable Breathe Free Lanka to facilitate easy access to Ultibro Breezhaler for patients in Sri Lanka to help them alleviate specific debilitating symptoms of COPD. 

As part of this agreement, Novartis will be responsible for manufacturing Ultibro Breezhaler at its global facilities in line with its commitment to quality, effectiveness and safety.

This development is in line with Cipla’s aim of addressing unmet patient needs in respiratory and other therapy areas in Sri Lanka. The company has a strong record of focusing its efforts on improving healthcare and enhancing access to innovative medicines for improved disease management and better quality of life, especially for patients who currently do not have easy access to critical medicines.

Cipla International Business Europe and Emerging Markets CEO Nishant Saxena said: “As market leaders with significant presence in the respiratory segment, we look forward to leveraging our marketing and distribution strengths in Sri Lanka to take this product to as many patients as possible in furtherance of our purpose of ‘Caring for Life’.”

Novartis Singapore and Asian Emerging Markets Managing Director Celine Landie said: “Our partnership with Cipla is aligned with the Novartis commitment to address the unmet medical needs of COPD patients and improving their quality of life by providing innovative medicines and devices.” 


Share This Article

Facebook Twitter


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Forensic Audits part of bond scam cover-up

Saturday, 25 January 2020

From the time the bond scam was carried out by the Ranil Wickremesinghe administration, that administration under the guidance of the former Prime Minister had been avoiding the law by regularly bringing up various distractions so that the true natur


Halting mega projects is untimely; Govt. can explore other options

Friday, 24 January 2020

In a Sunday newspaper on 5 January a news item titled ‘Mega projects on hold until August budget,’ ‘Drop in revenue after tax reductions prevents spending on major constructions,’ was not a development-friendly headline. It may be accurate o


Is any further expenditure on the Port City a waste of money?

Friday, 24 January 2020

Erase from the mind all that you have read and heard about it. Then take a blank piece of paper, draw an irregular circle, and draw a line to divide it into two. On the bottom half write 300 acres. That is our Port City! To get the size into a proper


Foundations of incivility

Friday, 24 January 2020

The lack of advanced political consciousness and democratic discipline can be considered as one of the main reasons for the crisis and the failure that Sri Lanka is facing. This can be considered a situation that has prevailed since independence. Sri


Columnists More